Migraine: preventive treatment

被引:180
|
作者
Silberstein, SD
Goadsby, PJ
机构
[1] Thomas Jefferson Univ Hosp, Jefferson Headache Ctr, Philadelphia, PA 19107 USA
[2] UCL Natl Hosp Neurol & Neurosurg, Inst Neurol, London WC1N 3BG, England
关键词
migraine; prevention; treatment; prophylaxis;
D O I
10.1046/j.1468-2982.2002.00386.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Migraine is a common episodic headache disorder. A comprehensive headache treatment plan includes acute attack treatment to relieve pain and impairment and long-term preventive therapy to reduce attack frequency, severity, and duration. Circumstances that might warrant preventive treatment include: (i) migraine that significantly interferes with the patient's daily routine despite acute treatment; (ii) failure, contraindication to, or troublesome side-effects from acute medications; (iii) overuse of acute medications; (iv) special circumstances, such as hemiplegic migraine; (v) very frequent headaches (more than two a week); or (vi) patient preference. Start the drug at a low dose. Give each treatment an adequate trial. Avoid interfering, overused, and contraindicated drugs. Re-evaluate therapy. Be sure that a woman of childbearing potential is aware of any potential risks. Involve patients in their care to maximize compliance. Consider co-morbidity. Choose a drug based on its proven efficacy, the patient's preferences and headache profile, the drug's side-effects, and the presence or absence of coexisting or co-morbid disease. Drugs that have documented high efficacy and mild to moderate adverse events (AEs) include beta-blockers, amitriptyline, and divalproex. Drugs that have lower documented efficacy and mild to moderate AEs include selective serotonin reuptake inhibitors (SSRIs), calcium channel antagonists, gabapentin, topiramate, riboflavin, and non-steroidal anti-inflammatory drugs.
引用
收藏
页码:491 / 512
页数:22
相关论文
共 50 条
  • [31] FINESSE: Fremanezumab for Preventive Treatment in Migraine
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schauerte, I.
    Neeb, L.
    CEPHALALGIA, 2021, 41 (1_SUPPL) : 174 - 175
  • [32] OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine
    Chen, Shih-Pin
    Fuh, Jong-Ling
    Wang, Shuu-Jiun
    CURRENT PAIN AND HEADACHE REPORTS, 2011, 15 (01) : 4 - 7
  • [33] OnabotulinumtoxinA: Preventive Treatment for Chronic Migraine
    Shih-Pin Chen
    Jong-Ling Fuh
    Shuu-Jiun Wang
    Current Pain and Headache Reports, 2011, 15 : 4 - 7
  • [34] THE ROLE OF THE NEUROMODULATORS IN THE PREVENTIVE TREATMENT OF MIGRAINE
    Pascual-Gomez, J.
    REVISTA DE NEUROLOGIA, 2009, 49 (01) : 25 - 32
  • [35] Memantine in the preventive treatment of refractory migraine
    Bigal, Marcelo
    Rapoport, Alan
    Sheftell, Fred
    Tepper, Deborah
    Tepper, Stewart
    HEADACHE, 2008, 48 (09): : 1337 - 1342
  • [36] New players in the preventive treatment of migraine
    Mitsikostas, Dimos D.
    Rapoport, Alan M.
    BMC MEDICINE, 2015, 13
  • [37] Zonisamide in the preventive treatment of refractory migraine
    Pascual-Gomez, Julio
    Gracia-Naya, Manuel
    Leira, Rogelio
    Mateos, Valentin
    Carlos Alvaro-Gonzalez, Luis
    Hernando, Ignacio
    Oterino, Agustin
    Iglesias-Diez, Fernando
    Caminero, Ana
    Carlos Garcia-Monco, Juan
    Forcea, Nerea
    Luis Guerrero-Peral, Angel
    Bueno, Valentin
    Santos-Garcia, Diego
    Perez, Celia
    Blanco, Miguel
    Pego-Reigosa, Robustiano
    Rodriguez, Rosa
    Mederer-Hengstl, Susana
    Pato-Pato, Antonio
    Sanchez-Herrero, Joaquin
    Luis Macineiras-Montero, Jose
    Ortega, Fernando
    Arias, Monica
    Diaz-Gonzalez, Manuel
    REVISTA DE NEUROLOGIA, 2010, 50 (03) : 129 - 132
  • [38] FINESSE: Fremanezumab for Preventive Treatment in Migraine
    Straube, A.
    Broessner, G.
    Gaul, C.
    Hamann, X.
    Kraya, T.
    Schauerte, I.
    Neeb, L.
    JOURNAL OF HEADACHE AND PAIN, 2021, 22 (SUPPL 1): : 117 - 117
  • [39] Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
    Blair, Hannah A.
    CNS DRUGS, 2023, 37 (03) : 255 - 265
  • [40] Rimegepant: A Review in the Acute Treatment and Preventive Treatment of Migraine
    Hannah A. Blair
    CNS Drugs, 2023, 37 : 255 - 265